Combining day treatment and outpatient treatment for eating disorders: findings from a naturalistic setting.


Journal

Eating and weight disorders : EWD
ISSN: 1590-1262
Titre abrégé: Eat Weight Disord
Pays: Germany
ID NLM: 9707113

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 17 10 2018
accepted: 16 01 2019
pubmed: 2 2 2019
medline: 5 1 2021
entrez: 2 2 2019
Statut: ppublish

Résumé

Day treatment programs for individuals with eating disorders (ED) have been the subject of research and are promoted as an alternative to inpatient treatment due to their therapeutic and economic advantages, but have not regularly been implemented in regular care. We investigated the long-term effectiveness of a transdiagnostic combined eating disorder treatment program which consisted of an 8-week day treatment phase followed by an average of 19 sessions of outpatient treatment over an average of 39 weeks in a naturalistic setting. We accepted 148 patients with different diagnoses of eating disorders into our combined treatment program. We assessed weight, behavioral eating disorder symptoms and eating disorder related cognitions and attitudes at the beginning and the end of the day treatment phase and after 6, 12 and 26 months. Over the course of the 8-week day treatment phase, patients with initial binge eating, purging and/or fasting behavior reduced these symptoms by 91%, 90% and, 86%. Patients who were underweight at baseline gained on average 1.05 BMI points (d = 0.76). In addition, eating disorder related cognitions and attitudes of all patients significantly improved with large effect sizes (d = 1.12). On average, all improvements remained stable during the follow-up period. Our findings add to the existing studies on day treatment and support previously found encouraging effects of treatment programs that combine day treatment and consecutive outpatient treatment for eating disorders. Level III, longitudinal cohort study.

Sections du résumé

BACKGROUND BACKGROUND
Day treatment programs for individuals with eating disorders (ED) have been the subject of research and are promoted as an alternative to inpatient treatment due to their therapeutic and economic advantages, but have not regularly been implemented in regular care.
PURPOSE OBJECTIVE
We investigated the long-term effectiveness of a transdiagnostic combined eating disorder treatment program which consisted of an 8-week day treatment phase followed by an average of 19 sessions of outpatient treatment over an average of 39 weeks in a naturalistic setting.
METHODS METHODS
We accepted 148 patients with different diagnoses of eating disorders into our combined treatment program. We assessed weight, behavioral eating disorder symptoms and eating disorder related cognitions and attitudes at the beginning and the end of the day treatment phase and after 6, 12 and 26 months.
RESULTS RESULTS
Over the course of the 8-week day treatment phase, patients with initial binge eating, purging and/or fasting behavior reduced these symptoms by 91%, 90% and, 86%. Patients who were underweight at baseline gained on average 1.05 BMI points (d = 0.76). In addition, eating disorder related cognitions and attitudes of all patients significantly improved with large effect sizes (d = 1.12). On average, all improvements remained stable during the follow-up period.
CONCLUSIONS CONCLUSIONS
Our findings add to the existing studies on day treatment and support previously found encouraging effects of treatment programs that combine day treatment and consecutive outpatient treatment for eating disorders.
LEVEL OF EVIDENCE METHODS
Level III, longitudinal cohort study.

Identifiants

pubmed: 30706362
doi: 10.1007/s40519-019-00643-6
pii: 10.1007/s40519-019-00643-6
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

519-530

Références

Psychother Psychosom. 2009;78(3):152-60
pubmed: 19270470
J Clin Psychol. 2002 Jul;58(7):833-46
pubmed: 12205723
Rehabilitation (Stuttg). 2004 Aug;43(4):241-6
pubmed: 15318292
Int J Eat Disord. 2009 Nov;42(7):636-47
pubmed: 19208386
Eat Weight Disord. 2001 Jun;6(2):81-9
pubmed: 11456425
Int J Eat Disord. 2014 Sep;47(6):565-84
pubmed: 24796817
Eur Eat Disord Rev. 2016 Jul;24(4):263-76
pubmed: 27062687
Eat Weight Disord. 2005 Dec;10(4):236-44
pubmed: 16755167
Int J Eat Disord. 2002 Jul;32(1):1-10
pubmed: 12183935
Int J Eat Disord. 2008 Sep;41(6):564-72
pubmed: 18570196
Eur Eat Disord Rev. 2010 May;18(3):220-33
pubmed: 20443205
Eur Eat Disord Rev. 2018 May;26(3):241-252
pubmed: 29542211
Aust N Z J Psychiatry. 2014 Nov;48(11):977-1008
pubmed: 25351912
Eur Eat Disord Rev. 2007 Jul;15(4):275-82
pubmed: 17676697
BMC Psychiatry. 2013 Nov 07;13:287
pubmed: 24200194
Rev Gen Psychol. 2013 Mar;17(1):111-121
pubmed: 23956615
Psychother Res. 2013;23(3):277-86
pubmed: 22989039
Eat Weight Disord. 2009 Jun-Sep;14(2-3):e31-41
pubmed: 19934635
Eur Eat Disord Rev. 2007 Jul;15(4):283-9
pubmed: 17676698
J Clin Psychol. 2011 Mar;67(3):318-27
pubmed: 21254059
Int J Eat Disord. 2011 Jan;44(1):29-38
pubmed: 20063371
J Adv Nurs. 2005 Jul;51(1):5-14
pubmed: 15941455
Eat Weight Disord. 2003 Sep;8(3):242-8
pubmed: 14649790
Eat Behav. 2009 Jan;10(1):16-21
pubmed: 19171312
Eur Eat Disord Rev. 2015 Sep;23(5):390-8
pubmed: 25974364
Eur Eat Disord Rev. 2008 Sep;16(5):341-51
pubmed: 18668700
Behav Res Ther. 2010 Mar;48(3):194-202
pubmed: 19945094
Int J Eat Disord. 2001 Jan;29(1):59-64
pubmed: 11135334
Med Care. 1989 Mar;27(3 Suppl):S178-89
pubmed: 2646488
Int J Eat Disord. 2017 Sep;50(9):1067-1074
pubmed: 28644568
Behav Res Ther. 2003 May;41(5):509-28
pubmed: 12711261
World J Psychiatry. 2015 Mar 22;5(1):147-53
pubmed: 25815264
Psychother Psychosom. 2011;80(4):216-26
pubmed: 21494063
Int J Eat Disord. 2012 Jul;45(5):635-47
pubmed: 22684990
Eat Disord. 2008 Oct-Dec;16(5):378-92
pubmed: 18821362
Eat Weight Disord. 2019 Feb;24(1):163-168
pubmed: 30027396
Lancet. 2014 Jan 11;383(9912):127-37
pubmed: 24131861
Int J Eat Disord. 2002 Mar;31(2):105-17
pubmed: 11920973
Int J Eat Disord. 2012 Apr;45(3):428-38
pubmed: 21744375
Am J Psychiatry. 2009 Mar;166(3):311-9
pubmed: 19074978
Am J Psychiatry. 2005 Dec;162(12):2374-6
pubmed: 16330603
Lancet. 2014 Apr 5;383(9924):1222-9
pubmed: 24439238
Eat Weight Disord. 2012 Sep;17(3):e170-7
pubmed: 23086252
Pharmacopsychiatry. 1991 Jan;24(1):1-7
pubmed: 2011615
Psychol Med. 2013 Dec;43(12):2477-500
pubmed: 23217606
Eat Disord. 2014;22(1):1-18
pubmed: 24365524
Eur Eat Disord Rev. 2007 Mar;15(2):98-111
pubmed: 17676678
Int J Eat Disord. 2005;37 Suppl:S26-30; discussion S41-2
pubmed: 15852315

Auteurs

Ina Beintner (I)

Institute of Clinical Psychology and Psychotherapy, Technische Universität Dresden, 01062, Dresden, Germany. Ina.Beintner@tu-dresden.de.

Kristian Hütter (K)

Institute of Clinical Psychology and Psychotherapy, Technische Universität Dresden, 01062, Dresden, Germany.

Katrin Gramatke (K)

Department of Child and Adolescent Psychiatry and Psychotherapy, Technische Universität Dresden, Universitätsklinikum Carl-Gustav-Carus, Schubertstraße 42, 01307, Dresden, Germany.

Corinna Jacobi (C)

Institute of Clinical Psychology and Psychotherapy, Technische Universität Dresden, 01062, Dresden, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH